Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Martek Announces Second Quarter 2008 Financial Results
Date:6/4/2008
ities 10,748 18,827
Stockholders' equity 566,448 531,727
Total liabilities and stockholders' equity $620,415 $596,695
Unaudited Condensed Consolidated Cash Flow Data
Six months ended
April 30,
2008 2007
Operating activities:
Net income $17,871 $7,619
Non-cash items 24,464 18,067
Changes in operating assets and liabilities, net (3,579) (17,896)
Net cash provided by operating activities 38,756 7,790
Investing activities:
(Purchase) sale of investments and marketable
securities, net (10,850) 6,850
Expenditures for property, plant and equipment (3,576) (3,059)
Repurchase of sale-leaseback equipment - (3,910)
Capitalization of intangible assets (2,165) (3,929)
Net cash used in investing activities (16,591) (4,048)
Financing activities:
Repayments of notes payable and other
long-term obligations, net (426) (505)
Repayments under revolving credit facility, net - (5,000)
Proceeds from stock option exercises and
other, net 5,944 1,903
Net cash provided by (used in) financing
activities 5,518 (3,602)
Net change in cash, cash equivalents 27,683 140
Cash and cash equivalents, beginning of period 16,973 15,578
Cash and cash equivalents, end of period
'/>"/>
| SOURCE Martek Biosciences Corporation Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Martek to Present at Upcoming UBS Conference
3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
7. Martek to Present at Upcoming ThinkEquity Partners Conference
8. Martek Announces Fourth Quarter and FY 2007 Financial Results
9. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
10. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
Post Your Comments:
(Date:5/22/2013)... FL (PRWEB) May 22, 2013 A recent ... of probiotics on athletes to find that those who took ... longer. The results from the study showed that in extreme ... Action, known for their adult acne treatment explains ... and how it may help their skin condition. , ...
(Date:5/22/2013)... Mass. , May 22, 2013 Moderna Therapeutics, ... new treatment modality to enable the in vivo ... John Reynders will join Moderna in ... Reynders is a proven leader in the ... of drug development, from discovery to translation, clinical operations ...
(Date:5/21/2013)... BEACH, Fla. , May 21, 2013 /PRNewswire/ ... FCN ), the global business advisory ... their enterprise value (the "Company"), announced that it ... personnel that were formerly included within the Corporate ... Litigation Consulting segment to form a single integrated ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Custom ... to reporting eLearning solution using Tin Can API ... dashboard tool. CLD is a leading developer of ... medical device companies worldwide. , Tin Can ... that helps learners and trainers more accurately measure ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3[0] Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers[0] Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer[0] FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice[0] CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard
... Singapore investigators to coordinate 700 patient trial of ... of head and neck cancer,MISSISSAUGA, ON, Jan. 5 ... TSX:YM, AIM:YMBA), an oncology company that identifies, develops ... announced that the National Cancer Centre of Singapore ...
... Penn Allegheny,Health System and The Western Pennsylvania Hospital announced ... Jones, MD, FACS,and Roger R. Barrette, MD, formerly of ... Drs. Jones and Barrette will direct the ... for the treatment of burn injuries. West Penn,is ...
... the backdrop of a flagging,economy, bailouts, and bleak ... with a future as bright as New Year,s ... market the Embozene(TM),Color-Advanced Microspheres embolization platform for the ... of blood vessels in many,locations) and arteriovenous malformations ...
Cached Biology Technology:YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 2YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 3YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 4West Penn Allegheny Health System Announces Recruitment of Leading Burn Specialists 2West Penn Allegheny Health System Announces Recruitment of Leading Burn Specialists 3First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 2First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 3First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 4(Date:5/21/2013)... , Where? Copenhagen, Denmark: Bella Center Congress ... , Why? An annual meeting ... developments, manufacturing and installation, drawing on leading experiences from ... edition from a record of more than 900 abstracts ... plenary and oral presentations, more than 460 visual presentation, ...
(Date:5/21/2013)... May 21, 2013 Royal Philips Electronics (NYSE: ... world,s first portable ultrasound with Philips, industry leading Live ... The CX50 xMATRIX with available Live 3D TEE and ... at the EuroPCR, official meeting for the European ... Since its launch in 2012, Philips CX50 xMATRIX ...
(Date:5/20/2013)... the antibiotic colistin are also commonly resistant to ... to a study in mBio , the ... Microbiology. Cross-resistance to colistin and host antimicrobials LL-37 ... bacterial attack, could mean that patients with life-threatening ... crippled immune response. Colistin is a last-line drug ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3... FASEB Journal provide more evidence that if we ... improve. According to MIT scientists, dietary nutrients found in ... eggs increase brain synapses and improve cognitive abilities. ... animals, respond to this kind of treatment by making ...
... State University faculty member who uses computational techniques ... is attracting worldwide attention from other researchers. ... and biomedical engineering at the Florida A&M University-Florida ... computers to determine how substances known as recombinant ...
... alarmed by the dramatic decline of at least 30 percent ... Nepal, once a refuge that boasted among the highest densities ... survey of April 2008 showed a population of between 6-14 ... Government of Nepal made a low-key announcement on July 1 ...
Cached Biology News:FSU researcher using computers to hone cancer-fighting strategies 2Tigers disappear from Himalayan refuge 2...
... antibody recognizes 30% of IgM-rheumatoid ... It does not cross-react with IgM, ... factor nor with pooled F(Ab)2 fragments. ... ELISA to detect rheumatoid factor. Product ...
...
Salmonella typhimurium Immunogen: Heat inactivated bacterial cells of Salmonella typhimurium B Storage: 4 C...
Biology Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |